184 related articles for article (PubMed ID: 28750488)
1. Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis.
Bao S; Zheng J; Li N; Huang C; Chen M; Cheng Q; Yu K; Chen S; Zhu M; Shi G
Gut Liver; 2017 Nov; 11(6):860-869. PubMed ID: 28750488
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection.
Huang C; Zheng JM; Cheng Q; Yu KK; Ling QX; Chen MQ; Li N
J Dig Dis; 2014 Nov; 15(11):614-21. PubMed ID: 25138057
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.
Zhang Q; Xu M; Qu Y; Li Z; Zhang Q; Cai X; Lu L
Mol Med Rep; 2015 Oct; 12(4):5647-54. PubMed ID: 26299203
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-17 levels in patients with hepatitis B virus induced liver fibrosis.
Gao F; Li K; Li Y; Ding GQ; Lu XL; Wang H; Liang XY; Wang J; Meng YY; Zhang L; Zeng YL
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6245-6251. PubMed ID: 32572891
[TBL] [Abstract][Full Text] [Related]
5. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
[TBL] [Abstract][Full Text] [Related]
6. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
[TBL] [Abstract][Full Text] [Related]
8. Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
J Viral Hepat; 2020 Jun; 27(6):602-609. PubMed ID: 31981279
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
Li L; Guo Z; Wang J; Mao Y; Gao Q
Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
[TBL] [Abstract][Full Text] [Related]
10. Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infection.
Huang C; Li Q; Xu W; Wang Q; Hu Q; Zhang X; Huang Y; Chen L
Discov Med; 2020; 29(157):119-128. PubMed ID: 33002408
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the predictive value of plateletcrit for the degree of liver fibrosis in patients with chronic HBV infection with ALT less than two times the upper limit of normal].
Wang B; Li Y; Xiao L; Xu HT; Xian JC
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):862-868. PubMed ID: 37723069
[No Abstract] [Full Text] [Related]
12. Analysis of Serum MicroRNA-122 Expression at Different Stages of Chronic Hepatitis B Virus Infection.
Liu W; He X; Huang F
Biomed Res Int; 2021; 2021():9957440. PubMed ID: 34212044
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
Wang H; Xu H; Qu L; Wang X; Wu R; Gao X; Jin Q; Niu J
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):997-1002. PubMed ID: 27167453
[TBL] [Abstract][Full Text] [Related]
14. Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B.
Ma LN; Liu XY; Luo X; Hu YC; Liu SW; Tang YY; Pan JL; Ding XC
Hepatogastroenterology; 2015; 62(138):368-72. PubMed ID: 25916065
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure.
Wen Y; Peng SF; Fu L; Fu XY; Wu DX; Liu BJ; Tan DM; Ouyang Y
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):126-132. PubMed ID: 29602672
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients.
Chen R; Wu JC; Liu T; Qu Y; Lu LG; Xu MY
J Dig Dis; 2017 Feb; 18(2):115-124. PubMed ID: 28127890
[TBL] [Abstract][Full Text] [Related]
18. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
19. [Establishment and evaluation of noninvasive diagnostic models for liver fibrosis in patients with chronic hepatitis B].
Yang Q; Liu DP; Li LP; Gu Y; Zhang MX; Liu Y; Yang K
Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):15-20. PubMed ID: 28297773
[No Abstract] [Full Text] [Related]
20. Serum miR-21 and miR-26a Levels Negatively Correlate with Severity of Cirrhosis in Patients with Chronic Hepatitis B.
Jiang S; Jiang W; Xu Y; Wang X; Mu Y; Liu P
Microrna; 2019; 8(1):86-92. PubMed ID: 30147020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
